Access to anti-retroviral drugs, female (%) in Bolivia
Bolivia: Access to anti-retroviral drugs, female (%) was 62.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Bolivia, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, female in Bolivia is 62.0%, measured in 2024. That is the highest value across all 25 years on record.
The figure is up 1.6% on the previous year and up 148.0% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Bolivia peaked at 62.0% in 2024 and was at its lowest, 0.0%, in 2000.
Bolivia ranks 99th of 141 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female (%) in Bolivia, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 1.0% | — |
| 2004 | 1.0% | +0.0% |
| 2005 | 2.0% | +100.0% |
| 2006 | 3.0% | +50.0% |
| 2007 | 3.0% | +0.0% |
| 2008 | 4.0% | +33.3% |
| 2009 | 7.0% | +75.0% |
| 2010 | 8.0% | +14.3% |
| 2011 | 9.0% | +12.5% |
| 2012 | 17.0% | +88.9% |
| 2013 | 20.0% | +17.6% |
| 2014 | 25.0% | +25.0% |
| 2015 | 34.0% | +36.0% |
| 2016 | 39.0% | +14.7% |
| 2017 | 43.0% | +10.3% |
| 2018 | 48.0% | +11.6% |
| 2019 | 51.0% | +6.2% |
| 2020 | 52.0% | +2.0% |
| 2021 | 57.0% | +9.6% |
| 2022 | 56.0% | -1.8% |
| 2023 | 61.0% | +8.9% |
| 2024 | 62.0% | +1.6% |
Bolivia compared with similar countries
- Bolivia's 62.0% is below the median for lower middle income countries, which is 80.0%, 78% of the median. (39 countries reporting)
- Bolivia's 62.0% is below the median for Latin America & Caribbean, which is 68.0%, 91% of the median. (23 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 2.1% | 0.0% | 7.0% | 10 |
| 2010s | 29.4% | 8.0% | 51.0% | 10 |
| 2020s | 57.6% | 52.0% | 62.0% | 5 |
Countries ranked near Bolivia
More gender data for Bolivia
- Child population (UN estimates and projections) 3,733 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 0.1438 % change on previous year (2030)
- Population 9,673 (2030)
- Working-age population (UN estimates and projections) 9,673 (2030)
- Population (UN estimates and projections), annual growth rate 1.64 % change on previous year (2030)
- Age population, age 00, female, interpolated 124,797 (2025)
- Age population, age 00, male, interpolated 129,451 (2025)
- Age population, age 01, female, interpolated 123,730 (2025)
- Age population, age 01, male, interpolated 128,219 (2025)
- Age population, age 02, female, interpolated 123,147 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Bolivia?
- Access to anti-retroviral drugs, female in Bolivia was 62.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Bolivia?
- The highest recorded value was 62.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Bolivia?
- The lowest recorded value was 0.0% in 2000.
- How does Bolivia rank for access to anti-retroviral drugs, female?
- Bolivia ranks 99th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Bolivia?
- Over the last ten years it is up 148.0%. The long-run trend across the full record is volatile.
- Where does this Bolivia data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.